載入...
New frontiers in the treatment of systemic juvenile idiopathic arthritis
Systemic juvenile idiopathic arthritis (sJIA) and its most significant complication, macrophage activation syndrome (MAS), have traditionally been treated with steroids and non-steroidal anti-inflammatory medications. However, the introduction of biologic medications that inhibit specific cytokines,...
Na minha lista:
| 發表在: | F1000Res |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
F1000Research
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482342/ https://ncbi.nlm.nih.gov/pubmed/28690841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.11327.1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|